Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution
نویسندگان
چکیده
منابع مشابه
Optimizing refolding condition for recombinant tissue plasminogen activator
Low molecular size additives such as L-arginine and the redox compounds have been used both in the culturemedium and in vitro refolding to increase recombinant proteins production. Additives increase proteinrefolding and yield of active proteins by suppressing aggregate formation or enhancing refolding process.In this work, a comparative study was performed on refolding of rec...
متن کاملThe Issues Related to Hemodialysis Catheter Lock Prophylaxis with Recombinant Tissue Plasminogen Activator
Arteriovenous fistulas (AVF) are the most preferred and promoted form of dialysis access due to their lowest complication rates. However, the changing demographic profile of endstage renal disease (ESRD) with an increasing elderly and diabetic population having relatively poor vasculature, relative lack of prudent pre-ESRD planning for AV fistula creation, late referrals, and comparatively lowe...
متن کاملCost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke
Stroke is a significant public health problem and one of the most costly diseases in the United States. Each year, ≈800 000 Americans experience a new or recurrent stroke and 134 000 deaths occur as a result of strokes. An estimated $74 billion were spent in 2010 on stroke-related medical costs and disability. The burden of disease from stroke is expected to increase over the coming decades bec...
متن کاملCost-effectiveness of tissue plasminogen activator for acute ischemic stroke.
Dates to which data relate Effectiveness and resource use data were extracted from NINDS rt-PA Stroke Trial conducted between January 1991 and October 1994, the results of which were published in 1995. Clinical probabilities relating to the epidemiological course of events were obtained from studies published between 1982 and 1997. The utility values related to different discharge states were b...
متن کاملAge-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke
INTRODUCTION Studies have demonstrated that intravenous recombinant tissue plasminogen activator (IV rtPA) is a cost-effective treatment for acute ischemic stroke. Age-specific cost effectiveness has not been well examined. This study estimated age-specific incremental cost-effectiveness ratios (ICERs) of IV rtPA treatment versus no IV rtPA. METHODS A Markov model was developed to examine the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Journal of the American Society of Nephrology
سال: 2018
ISSN: 1555-9041,1555-905X
DOI: 10.2215/cjn.08510817